Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 88
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00983099 | Evaluation of Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of Neramexane Mesylate in Healthy Japanese Subjects | ||
| NCT02462317 | Study of the Effects on Motor Recovery of Early Post-stroke Spasticity Treatment | ||
| NCT04177212 | Investigation of the Effectiveness and Safety of MRZF111 in the Treatment of Décolleté Wrinkles | ||
| NCT00777803 | NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines | ||
| NCT01405482 | Botulinum Toxin Injections for Thoracic Outlet Syndrome | ||
| NCT02577224 | An RCT of a Patient-initiated Treatment Service for BEB and HFS | ||
| NCT00804271 | Memantine and Validation of a New Alzheimer's Disease Scale | ||
| NCT05943860 | Efficacy and Tolerability of Pantovigar® Vegan in Female Subjects With Diffuse Hair Loss | ||
| NCT01714960 | Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma Patients | ||
| NCT00507637 | Blepharospasm Short Interval | ||
| NCT03256942 | Evaluation of the Sensitivity of Merz Lips Fullness Assessment Scale Following Etermis 4® Treatment for Lips Volume Augmentation | ||
| NCT00430586 | Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown Lines | ||
| NCT00432666 | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Post-stroke Spasticity of the Upper Limb | ||
| NCT02091739 | Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions | ||
| NCT01603459 | Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm | ||
| NCT00978614 | Evaluation of Dose-Dependent Repeated-Dose Neramexane Effects on Cardiac Repolarisation (QT/QTc Interval Duration): Electrocardiogram (ECG) Study in Healthy Adult Subjects | ||
| NCT01112371 | Contractubex Treatment in Scars After Abdominal Caesarean Section | ||
| NCT04594213 | Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial Lines | ||
| NCT00407030 | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Cervical Dystonia | ||
| NCT04766723 | A Study to Investigate the Efficacy and Safety of NT 201 (Botulinum Toxin) Compared With Placebo for the Treatment of Adult Participants With Essential Tremor in the Arm | ||
| NCT00915174 | Study to Evaluate the Effects of Neramexane on the Pharmacokinetics of a Combined Drospirenone/Ethinyl Estradiol Oral Contraceptive in Healthy Female Subjects | ||
| NCT01905683 | Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy | ||
| NCT01910896 | Effectiveness and Safety Study of Overnight Intensive Patch in Scars | ||
| NCT00772980 | Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective Tinnitus | ||
| NCT01109680 | A Single Center, Open-Label Study to Quantify Metabolites of [14C]-Neramexane in Plasma and Urine in Healthy Male Subjects | ||
| NCT05884528 | Assessment of Long-term Clinical Response to BoNT in Cervical Dystonia | ||
| NCT01515371 | Dose Finding Study for a Botulinum Toxin Type A Injection to Treat Habitual Snoring | ||
| NCT07018713 | A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine | ||
| NCT00649220 | Memantine and Antipsychotics Use | ||
| NCT04622254 | Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Crows Feet) in Subjects With Moderate to Severe Upper Facial Lines | ||
| NCT02002884 | Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy | ||
| NCT03986424 | Local Study of Akatinol Memantine in VaD in Russia | ||
| NCT05327972 | DEgenerative ROtator Cuff Disease and Botulinum TOXin | ||
| NCT01896895 | Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid | ||
| NCT01098019 | Treatment of Notalgia Paresthetica With Xeomin | ||
| NCT02270736 | Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual Disability | ||
| NCT01565395 | Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS) | ||
| NCT03650387 | Safety, Effectiveness and Participant Satisfaction Study of a Dermal Filler (of RADIESSE® (+) Lidocaine) in the Treatment of Ageing Signs in the Face | ||
| NCT00406367 | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm | ||
| NCT00799942 | Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired Nystagmus | ||
| NCT00739635 | Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus | ||
| NCT00955799 | Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus | ||
| NCT00541905 | Daily Dystonia Practice - A Trial to Investigate NT 201, the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Cervical Dystonia | ||
| NCT01900041 | A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss | ||
| NCT00770029 | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines No. 2 | ||
| NCT04210258 | Post-Market Clinical Follow-up Performance and Safety Study of Etermis 3 and 4 in the Face | ||
| NCT00936026 | Open, Single Center, Three Periods, Fixed Sequence Design Study on the Effects of Clopidogrel Co-administration on the Pharmacokinetics of Neramexane | ||
| NCT00512135 | Safety and Efficacy of NT 201 (IncobotulinumtoxinA [Xeomin]) in the Treatment of Glabellar Frown Lines | ||
| NCT00827008 | Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus | ||
| NCT06995287 | Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Severe Primary Dysmenorrhea |
